High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.
about
Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic reviewRespiratory syncytial virus infections enhance cigarette smoke induced COPD in miceRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Challenges and opportunities in developing respiratory syncytial virus therapeuticsRespiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital.Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical managementGS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion ProcessPhenotypic and molecular study of pneumococci causing respiratory tract infections. A 3-year prospective cohort.SOFIA®RSV: prospective laboratory evaluation and implementation of a rapid diagnostic test in a pediatric emergency ward.Current concepts and progress in RSV vaccine development.Agents that increase AAM differentiation blunt RSV-mediated lung pathology.Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study.Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012.Utilization of the respiratory virus multiplex reverse transcription-polymerase chain reaction test for adult patients at a Korean tertiary care center.A gene expression signature for RSV: clinical implications and limitations.Deaths associated with respiratory syncytial and influenza viruses among persons ≥5 years of age in HIV-prevalent area, South Africa, 1998-2009(1).Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.Estimating the hospitalization burden associated with influenza and respiratory syncytial virus in New York City, 2003-2011.The burden of influenza-associated critical illness hospitalizationsSafety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phasChimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.Viral Respiratory Infections of Adults in the Intensive Care Unit.Viral glycoproteins: biological role and application in diagnosis.Update in Viral Infections 2014.Novel therapies and vaccines against the human respiratory syncytial virus.Therapeutic efficacy of a respiratory syncytial virus fusion inhibitorRespiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting.Structure-guided design of small-molecule therapeutics against RSV disease.Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease.Respiratory Syncytial Virus Infection: An Illness for All Ages.Factors predicting life-threatening infections with respiratory syncytial virus in adult patients.The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit.Clinical Evaluation of the New High-Throughput Luminex NxTAG Respiratory Pathogen Panel Assay for Multiplex Respiratory Pathogen Detection.GS-5806 inhibits pre- to postfusion conformational changes of the respiratory syncytial virus fusion protein.High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus Infections.Respiratory syncytial virus infection in older adults: an under-recognized problem.Respiratory syncytial virus hospitalization in middle-aged and older adults.Protecting the family to protect the child: vaccination strategy guided by RSV transmission dynamicsThe impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study.Multiplex Respiratory Virus Testing for Antimicrobial Stewardship: A Prospective Assessment of Antimicrobial Use and Clinical Outcomes Among Hospitalized Adults.
P2860
Q26768419-6E3F7E6F-A97C-463D-BE49-523ED11A3D14Q27317947-B52D9CA7-3811-4BD0-813E-F0C966AF9D9EQ30240274-91912D19-8612-49D7-A359-CEF573B5D33CQ30300567-32D0CB7D-BB5F-4C8D-9B2B-7F532DE4D088Q30358632-E692D562-B651-4D3E-93E2-AA356A448B12Q30368680-A6448271-75DA-48CA-898F-494EE6DA9B29Q30375062-A240E097-2F93-4642-8EB1-3ACF05CC21B7Q33735215-D9A969B4-E754-45C7-9F7B-DEE645252019Q33836656-23A73180-D400-46E5-A1BC-66B2569FB71AQ34396689-47EE0ABF-17F3-4FC6-9825-858BB0A8BE82Q34484085-1D1BBF49-50A2-408C-A6EF-587ABC710A0AQ34728523-EDB64541-E271-48D8-AB2A-1B54202294D0Q34781034-D984FC4E-9445-4F23-B407-3554E0886438Q34948266-2EF85F96-D083-4E68-8156-FF0B4AC154EAQ35050237-1A7C6CC7-BBFA-4257-B482-9C7AC8E938E3Q35229634-358D8C7C-465F-4B85-B22C-411D5DFD388DQ35763742-C71C2F5B-6634-4119-99B5-68CAE2060A93Q35994969-3D5F6B70-77A9-48B4-88BA-CFDEC6F1DE2CQ36204702-F0519FF0-30F5-449F-ABD2-014CBBF0B014Q36258838-E39372EC-5F81-4696-AEB4-8EA00E94FEB2Q36347381-50D2DA6A-32E8-4235-BC27-FE78B0D5917BQ38491990-B561445D-F33C-45CD-BFEC-F55462691292Q38543883-C8A4F1A9-7377-41C3-9AD6-F754955F6BC1Q38587113-7769CE1D-EA03-417C-B37D-752564EC3DA8Q38604787-80637905-02F6-4B95-98FA-6CE589992A3EQ38650711-FECFD7EB-3D2E-4DB5-8705-194242FD801EQ38693999-5FA6FB04-03CE-4BA3-BF0B-E10DF67C9CEDQ38798541-1A9C458C-8517-4E24-B0C1-52C8FA051F79Q38998557-3F28C571-AD7C-4B02-8685-ABB5F99415F7Q39118423-D9EE7687-91C0-4619-BCD9-9349101039B2Q39136472-52DBFDEE-E398-41AC-8AE1-5B281A55F592Q40316430-C9CA827A-96A1-4E3C-B334-3825FF3BED19Q40696053-73021634-672A-49CA-B41F-1989EFA1B0B6Q41023216-7D62C21D-12E0-4B5E-9192-89654132A163Q41025769-DC3FC4DF-2113-468A-BA92-26FB6A586296Q41349182-BE6F974D-A3BD-41C9-B299-92A46946722FQ41931250-64F7A65D-D5BE-447F-B8B5-A06B0A2A9126Q42600725-8C37771C-8820-459A-BBCB-C0E0972A7628Q45323718-F2C7A75C-A8D1-407E-B478-49AA1A166586Q45324682-AAEB1F52-E776-4D2A-8EEC-AE0856DA22BB
P2860
High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
High morbidity and mortality i ...... ry syncytial virus infections.
@en
High morbidity and mortality i ...... ry syncytial virus infections.
@nl
type
label
High morbidity and mortality i ...... ry syncytial virus infections.
@en
High morbidity and mortality i ...... ry syncytial virus infections.
@nl
prefLabel
High morbidity and mortality i ...... ry syncytial virus infections.
@en
High morbidity and mortality i ...... ry syncytial virus infections.
@nl
P2093
P2860
P50
P356
P1476
High morbidity and mortality i ...... ory syncytial virus infections
@en
P2093
J Y C Chan
K L K Ngai
P K S Chan
R Y K Wong
S S M Wong
P2860
P304
P356
10.1093/CID/CIT471
P407
P577
2013-07-21T00:00:00Z